A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER
Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
Frontiers In Oncology
D'mello, Stacey Ann N SA; Flanagan, Jack U JU; Green, Taryn N TN; Leung, Euphemia Y EY; Askarian-Amiri, Marjan E ME; Joseph, Wayne R WR; McCrystal, Michael R MR; Isaacs, Richard J RJ; Shaw, James H F JH; Furneaux, Christopher E CE; During, Matthew J MJ; Finlay, Graeme J GJ; Baguley, Bruce C BC; Kalev-Zylinska, Maggie L ML